PD-166285 blocks the activity of Src kinases, which are involved in various cellular processes such as growth, differentiation, and survival, and have been implicated in the progression of several cancers and other diseases.
Molecular Weight
585.35
Molecular Formula
C26H29Cl4N5O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
PD-166285 inhibits Src family kinases, aiding research in the development of cancer therapies involving kinase signaling.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
